Jacobio Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Jacobio Pharmaceuticals Co., Ltd., explained in plain language.
A China-based biopharmaceutical company focused on developing cancer therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill takes aim at Hard-to-Treat KRAS cancers Results expected Dec 2026 (estimated)
- New pill targets rare cancer mutation in early trial Results expected Jan 2027 (estimated)
- New pill aims to tame rheumatoid arthritis inflammation Results expected Jun 2027 (estimated)